Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rafael Holdings, Inc. | CFO & President | Class B Common Stock, par value $.01 per share | 335K | $607K | $1.81 | Dec 21, 2022 | Direct |
Protara Therapeutics, Inc. | Chief Financial Officer | Common Stock | 22K | $42K | $1.91 | Jan 19, 2024 | Direct |
Protara Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 131K | Jan 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TARA | Protara Therapeutics, Inc. | Jan 19, 2024 | 2 | $0 | 4 | Jan 23, 2024 | Chief Financial Officer |
TARA | Protara Therapeutics, Inc. | Jan 30, 2023 | 1 | $0 | 4 | Jan 30, 2023 | Chief Financial Officer |
TARA | Protara Therapeutics, Inc. | Jan 30, 2023 | 0 | $0 | 3 | Jan 30, 2023 | Chief Financial Officer |
RFL | Rafael Holdings, Inc. | Dec 21, 2022 | 1 | -$49.2K | 4 | Dec 23, 2022 | CFO & President |
RFL | Rafael Holdings, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | CFO & President |
RFL | Rafael Holdings, Inc. | Sep 17, 2021 | 1 | $0 | 4 | Sep 20, 2021 | Chief Financial Officer |
RFL | Rafael Holdings, Inc. | Sep 13, 2021 | 0 | $0 | 3 | Sep 17, 2021 | Chief Financial Officer |